Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 261 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 27,427.0 | $410K | 0.10% | -5K | -15.8% | $14.94 | -0.7% |
| 262 | — | AVALO THERAPEUTICS INC | — | 22,168.0 | $410K | 0.10% | NEW | — | $18.48 | — |
| 263 | — | DAMORA THERAPEUTICS INC | — | 15,746.0 | $410K | 0.10% | NEW | — | $26.01 | — |
| 264 | — | OCULIS HOLDING AG | — | 29,504.0 | $409K | 0.10% | NEW | — | $13.87 | — |
| 265 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 7,622.0 | $409K | 0.10% | +4K | +87.5% | $53.67 | -0.3% |
| 266 | LXRX | LEXICON PHARMACEUTICALS INC | Healthcare | 170,415.0 | $409K | 0.10% | NEW | — | $2.40 | +0.8% |
| 267 | REPL | REPLIMUNE GROUP INC | Healthcare | 36,846.0 | $408K | 0.10% | +10K | +37.6% | $11.07 | +40.7% |
| 268 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 108,703.0 | $408K | 0.10% | +44K | +67.0% | $3.75 | -9.6% |
| 269 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 7,406.0 | $407K | 0.10% | +2K | +27.3% | $55.00 | -0.5% |
| 270 | PROK | PROKIDNEY CORP | Healthcare | 199,510.0 | $407K | 0.10% | +76K | +61.7% | $2.04 | -32.4% |
| 271 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 118,981.0 | $407K | 0.10% | +39K | +47.9% | $3.42 | -2.3% |
| 272 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 13,605.0 | $406K | 0.10% | +7K | +93.9% | $29.84 | -2.4% |
| 273 | HTGC | HERCULES CAPITAL INC | Financial Services | 25,577.0 | $403K | 0.09% | -9K | -26.2% | $15.77 | +5.6% |
| 274 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 22,426.0 | $403K | 0.09% | +2K | +7.7% | $17.96 | +95.5% |
| 275 | GBDC | GOLUB CAP BDC INC | Financial Services | 31,259.0 | $403K | 0.09% | -17K | -35.4% | $12.88 | +1.5% |
| 276 | ANRO | ALTO NEUROSCIENCE INC | Healthcare | 15,239.0 | $402K | 0.09% | NEW | — | $26.39 | +29.3% |
| 277 | PCVX | VAXCYTE INC | Healthcare | 6,894.0 | $401K | 0.09% | +768.0 | +12.5% | $58.13 | +2.9% |
| 278 | SION | SIONNA THERAPEUTICS INC | Healthcare | 9,109.0 | $401K | 0.09% | +3K | +42.9% | $43.99 | -86.5% |
| 279 | DYN | DYNE THERAPEUTICS INC | Healthcare | 17,988.0 | $400K | 0.09% | +4K | +27.1% | $22.21 | +17.1% |
| 280 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 38,721.0 | $399K | 0.09% | NEW | — | $10.31 | +14.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%